Key result
Acetylcholine provocation testing safely identifies vasospastic angina in ~44% of patients with INOCA.
Why the study?
Despite guideline recommendations for invasive functional testing in INOCA, its implementation in routine clinical practice remains limited. This study evaluated a standardized acetylcholine provocation protocol to differentiate clinical endotypes and optimize the diagnostic algorithm for personalized treatment.
Does invasive functional testing with a standardized acetylcholine provocation protocol differentiate clinical endotypes and demonstrate procedural safety in patients with INOCA?
Observational (n=68)
No
Does invasive functional testing with a standardized acetylcholine provocation protocol differentiate clinical endotypes and demonstrate procedural safety in patients with INOCA?
Answers are grounded in this paper and cite their sources.
Invasive endotyping via a standardized acetylcholine provocation protocol is safe and identifies specific underlying mechanisms in INOCA patients—predominantly vasospastic angina, endothelial dysfunction, and symptomatic myocardial bridges—enabling personalized therapy.
Background Ischemia with Non-Obstructive Coronary Arteries (INOCA) is associated with a more than three-fold increase in the risk of major adverse cardiovascular events, including myocardial infarction and heart failure, compared to the healthy population. Despite current guidelines recommending invasive functional testing, its implementation remains limited in routine clinical practice. We present our experience in implementing a standardized acetylcholine (Ach) provocation protocol for precise endotyping of INOCA patients. Purpose To improve the diagnostic efficiency and personalized treatment of patients with INOCA by differentiating clinical endotypes and optimizing the diagnostic algorithm. Methods The study enrolled 68 patients with symptoms of coronary artery disease who presented to our center between February 2025 and January 2026. All patients underwent a clinical evaluation, including echocardiography and a graded exercise stress test. Subsequently, all patients underwent coronary angiography, supplemented by an acetylcholine provocation test. In patients with evidence of coronary atherosclerosis, fractional flow reserve (FFR) was measured to exclude the hemodynamic significance of stenoses Results The mean age of the patients was 57.7 ± 10.5 years. Women accounted for 42.6%. Among the risk factors, hypertension (91.2%), dyslipidemia (50.0%), smoking (23.5%), and diabetes mellitus (13.2%) prevailed. Following the acetylcholine provocation test, the following conditions were verified: endothelial dysfunction – 26.5%, vasospastic angina – 44.1%, microvascular spasm – 11.8%, and symptomatic myocardial bridges – 17.6%. Overall, 54.4% of bridges were detected, but they were not associated with spasm in all patients. The procedure was safe; transient complications, including AV blocks (13.2%) and supraventricular arrhythmias (4.4%), were self-limiting and successfully managed in the catheterization laboratory. Conclusion Invasive endotyping via acetylcholine provocation is safe and provides essential diagnostic clarity in patients with INOCA. Our findings highlight the significant role of symptomatic myocardial bridges in triggering vasospasm, a mechanism often overlooked during routine angiography. Implementing this standardized protocol—the first of its kind in Ukraine—facilitates a paradigm shift from empirical management to personalized, endotype-specific therapy, which is crucial for improving clinical outcomes in this underserved patient population.
No takes yet. Share an insight, caveat, or question.
Levchuk et al. (2026) conducted an observational in Ischemia with Non-Obstructive Coronary Arteries (INOCA) (n=68). Invasive acetylcholine provocation test was evaluated on Prevalence of clinical INOCA endotypes (vasospastic angina, endothelial dysfunction, symptomatic myocardial bridges, and microvascular spasm). Acetylcholine provocation testing safely identified vasospastic angina, endothelial dysfunction, symptomatic myocardial bridges, and microvascular spasm in INOCA.
Synapse has enriched 10 related papers. Consider them for comparative context: